Current Report Filing (8-k)
January 09 2020 - 05:01PM
Edgar (US Regulatory)
false
STERICYCLE INC
0000861878
0000861878
2020-01-06
2020-01-06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 6, 2020
Stericycle, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
1-37556
|
36-3640402
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification Number)
|
2355 Waukegan Road
Bannockburn, Illinois 60015
(Address of principal executive offices including zip code)
(847) 367-5910
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
SRCL
|
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On January 9, 2020, Stericycle, Inc. (the “Company”) announced that Kurt M. Rogers, Executive Vice President and General Counsel, will be stepping down from his position effective as of January 31, 2020. The Company thanks Mr. Rogers for his service to the Company and his many valuable contributions.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
Dated: January 9, 2020
|
|
Stericycle, Inc.
|
|
|
|
|
By:
|
/s/ Janet H. Zelenka
|
|
|
|
|
|
Janet H. Zelenka
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
Stericycle (NASDAQ:SRCL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Stericycle (NASDAQ:SRCL)
Historical Stock Chart
From Mar 2023 to Mar 2024